Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | LTBP2 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | SRSF10 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | RBBP4 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | AHNAK | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | CERCAM | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | LBR | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |